Clinical risk factors for early mortality in patients with community-acquired septic shock. The importance of adequate source control

被引:0
|
作者
Valles, J. [1 ]
Diaz, E. [1 ]
Oliva, J. Carles [1 ]
Martinez, M. [1 ]
Navas, A. [1 ]
Mesquida, J. [1 ]
Gruartmoner, G. [1 ]
de Haro, C. [1 ]
Mestre, J. [1 ]
Guia, C. [1 ]
Rodriguez, A. [1 ]
Ochagavia, A. [1 ]
机构
[1] Hosp Univ Parc Tauli, Fundacio Parc Tauli, Crit Care Dept, Sabadell, Spain
关键词
Community-acquired infections; Septic shock; ICU; Early mortality; Source control; SURVIVING SEPSIS CAMPAIGN; ACUTE LUNG INJURY; TRENDS; MANAGEMENT; INFECTION; OUTCOMES; THERAPY; FAILURE; IMPACT; ADULTS;
D O I
10.1016/j.medin.2020.05.008
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To evaluate the incidence and risk factors for early mortality (EM) in the ICU in patients with community-acquired septic shock (CASS). Design: A retrospective cohort study of patients with CASS admitted to the ICU (2003-2016). Setting: ICU at a University Hospital in Spain. Patients: All consecutive patients admitted to the ICU with CASS. Interventions: None. Main variables of interest: CASS was defined according to the Sepsis-3 definitions. EM were defined as occurring within of 72 h following ICU admission. A multinomial logistic regression analysis was performed to identify the risk factors associated with early deaths. Results: During the study period, 625 patients met the Sepsis-3 criteria and admitted with CASS. 14.4% of all patients died within the first 72 h. Of 161 patients who died in the ICU, 90 (55.9%) died within the first 72 h. The percentage of early and late mortality did not vary significantly during the study period. The need and adequacy of source control were significantly lower in patients with EM. In the multivariate analysis, ARDS, non-respiratory infections, bacteremia and severity at admission were variables independently associated with EM. The only factor that decreased EM was adequate source control in patients with infections amenable to source control. Conclusions: The incidence of EM has remained stable over time, which means that more than half of the patients who die from CASS do so within the first 72 h. Infections where adequate source control can be performed have lower EM. (C) 2020 Elsevier Espana, S.L.U. y SEMICYUC. All rights reserved.
引用
收藏
页码:541 / 551
页数:11
相关论文
共 50 条
  • [41] The effectiveness of the sarcopenia index in predicting septic shock and death in elderly patients with community-acquired pneumonia
    Huang, Sha
    Zhao, Lingdan
    Liu, Zhaoyuan
    Li, Yang
    Wang, Xi
    Li, Jianqun
    Chen, Xiaoyan
    BMC GERIATRICS, 2022, 22 (01)
  • [42] Risk factors for pulmonary embolism in patients preliminarily diagnosed with community-acquired pneumonia: a prospective cohort study
    Zhang, Yunfeng
    Zhou, Qixing
    Zou, Ying
    Song, Xiaolian
    Xie, Shuanshuan
    Tan, Min
    Zhang, Guoliang
    Wang, Changhui
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2016, 41 (04) : 619 - 627
  • [43] Critical Illness Factors Associated With Long-Term Mortality and Health-Related Quality of Life Morbidity Following Community-Acquired Pediatric Septic Shock*
    Zimmerman, Jerry J.
    Banks, Russell
    Berg, Robert A.
    Zuppa, Athena
    Newth, Christopher J.
    Wessel, David
    Pollack, Murray M.
    Meert, Kathleen L.
    Hall, Mark W.
    Quasney, Michael
    Sapru, Anil
    Carcillo, Joseph A.
    McQuillen, Patrick S.
    Mourani, Peter M.
    Wong, Hector
    Chima, Ranjit S.
    Holubkov, Richard
    Coleman, Whitney
    Sorenson, Samuel
    Varni, James W.
    McGalliard, Julie
    Haaland, Wren
    Whitlock, Kathryn
    Dean, J. Michael
    Reeder, Ron W.
    CRITICAL CARE MEDICINE, 2020, 48 (03) : 319 - 328
  • [44] Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study)
    Povoa, Pedro R.
    Carneiro, Antonio H.
    Ribeiro, Orquidea S.
    Pereira, Altamiro C.
    CRITICAL CARE MEDICINE, 2009, 37 (02) : 410 - 416
  • [45] Mortality prediction using serum biomarkers and various clinical risk scales in community-acquired pneumonia
    Kim, Min Woo
    Lim, Jee Yong
    Oh, Sang Hoon
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2017, 77 (07) : 486 - 492
  • [46] Incidence, Etiology, Timing, and Risk Factors for Clinical Failure in Hospitalized Patients With Community-Acquired Pneumonia
    Aliberti, Stefano
    Amir, Asad
    Peyrani, Paula
    Mirsaeidi, Mehdi
    Allen, Marty
    Moffett, Brian K.
    Myers, John
    Shaib, Fidaa
    Cirino, Maria
    Bordon, Jose
    Blasi, Francesco
    Ramirez, Julio A.
    CHEST, 2008, 134 (05) : 955 - 962
  • [47] Risk Factors for Hospitalization Due to Community-Acquired Sepsis - A Population-Based Case-Control Study
    Henriksen, Daniel Pilsgaard
    Pottegard, Anton
    Laursen, Christian B.
    Jensen, Thoger Gorm
    Hallas, Jesper
    Pedersen, Court
    Lassen, Annmarie Touborg
    PLOS ONE, 2015, 10 (04):
  • [48] Trajectory of Mortality and Health-Related Quality of Life Morbidity Following Community-Acquired Pediatric Septic Shock*
    Zimmerman, Jerry J.
    Banks, Russell
    Berg, Robert A.
    Zuppa, Athena
    Newth, Christopher J.
    Wessel, David
    Pollack, Murray M.
    Meert, Kathleen L.
    Hall, Mark W.
    Quasney, Michael
    Sapru, Anil
    Carcillo, Joseph A.
    McQuillen, Patrick S.
    Mourani, Peter M.
    Wong, Hector
    Chima, Ranjit S.
    Holubkov, Richard
    Coleman, Whitney
    Sorenson, Samuel
    Varni, James W.
    McGalliard, Julie
    Haaland, Wren
    Whitlock, Kathryn
    Dean, J. Michael
    Reeder, Ron W.
    CRITICAL CARE MEDICINE, 2020, 48 (03) : 329 - 337
  • [49] Risk factors for mortality in patients with low lactate level and septic shock
    Oh, Dong Hyun
    Kim, Moo Hyun
    Jeong, Woo Yong
    Kim, Yong Chan
    Kim, Eun Jin
    Song, Je Eun
    Jung, In Young
    Jeong, Su Jin
    Ku, Nam Su
    Choi, Jun Yong
    Song, Young Goo
    Kim, June Myung
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2019, 52 (03) : 418 - 425
  • [50] Risk factors for complicated community-acquired pneumonia course in patients treated with β-lactam monotherapy
    Cincileviciute, Giedre
    Averjanovaite, Vaida
    Mereskeviciene, Ruta
    Pliatkiene, Gabriele
    Zablockis, Rolandas
    Danila, Edvardas
    ADVANCES IN RESPIRATORY MEDICINE, 2021, 89 (04) : 359 - 368